Science Group (SAG.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold SAG.L in your mock portfolio yet.
With an EPS of 0.74 and a PE ratio of 7.91, Science Group appears modestly profitable and valued at a discount relative to many broader equity markets, which can imply either undervaluation or low growth expectations. The limited data does not show clear revenue or margin trends, so it is difficult to conclude that earnings quality or growth is strong. Overall, the valuation looks conservative, but the absence of growth indicators keeps the view neutral.
The stock trades at $585.00, only modestly above its 200-day moving average of $554.79, indicating a slight positive long-term trend but not a strong momentum breakout. The price is flat over the last month (0.0% change), suggesting a consolidation phase with neither strong buying nor selling pressure. Without explicit RSI data, there is no clear overbought or oversold signal, reinforcing a neutral technical stance.
Estimated web traffic of 2,810 visitors per month and a LinkedIn following of 3,708 suggest a relatively small digital footprint, which may limit brand reach and new business visibility. The company currently has 0 job openings, which could indicate a lack of active expansion or hiring momentum, often a negative signal for near-term growth. Taken together, these alternative data points lean slightly bearish for growth expectations, although they may be partly explained by the company’s niche or B2B focus.
Overall, Science Group’s stock presents a neutral outlook: the low PE and positive EPS show underlying profitability and potential value, but the lack of visible growth signals and subdued alternative data temper enthusiasm. Technicals point to a mildly positive long-term trend with flat short-term performance, suggesting investors are in a wait-and-see mode. Unless clearer evidence of revenue or earnings growth emerges, the balance of signals supports a neutral stance.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started